Stayble strengthens its scientific advisory board with US-focused key opinion leaders
Stayble Therapeutics today announced that the company’s continue to strengthen its scientific advisory board with two new members – Dr. Aaron Calodney and Dr. Douglas Beall. Their respective expertise and experience within spine-related issues and pain management adds important insights as well as US perspectives.“We are very excited about Stayble getting more access to international expertise in our research area particularly with a US perspective. Not only is the US a key market for us, but there is an incredible drive for medical innovation that it is key for us to tap into to continue